PedAM
Pediatric Disease Annotations & Medicines
| Disease | mental depression |
| Phenotype | C0002395|alzheimer\'s disease |
| Sentences | 39 |
| PubMedID- 23116976 | The aim of this study was to analyze the medical history, with regards to previous remote depression, in patients with neuropathologically verified alzheimer's disease (ad), vascular dementia (vad) and mixed ad/vad. |
| PubMedID- 23863098 | The low blood level of folates is the primary cause of depression in alzheimer's disease. |
| PubMedID- 25061711 | Objective: depression is common in patients with alzheimer's disease (ad) and mild cognitive impairment (mci). |
| PubMedID- 24474984 | Reported an auc figure of 0.76 for provisional criteria for depression in alzheimer's disease (pcd-dad) among patients with early-on-set dementia and also among proxy informants,12,13 which corresponds with the results of barca et al.17 and watson et al.,18 who examined the validity of the csdd among patients in ltc homes. |
| PubMedID- 21747995 | Elevated apathy scores were associated with low depression in alzheimer's disease, high depression in major depression, and intermediate scores for depression in right hemispheric stroke. |
| PubMedID- 26508963 | Objective: comorbid depression is common in patients with alzheimer's disease (ad). |
| PubMedID- 20129320 | Objectives: we compared the prevalence of subtypes of depression in patients with alzheimer's disease (ad), vascular dementia (vad), and unspecified dementia (ud). |
| PubMedID- 23079957 | Effect of selective serotonin reuptake inhibitors in alzheimer's disease with comorbid depression: a meta-analysis of depression and cognitive outcomes. |
| PubMedID- 25999979 | High prevalence of depression in individuals with alzheimer's disease can be expected because alzheimer's disease causes serotoninergic deficit, and some data indicate that this deficit may be related to aggressive behaviors [31,32]. |
| PubMedID- 20573052 | Aims: the aims of this study were to assess the epidemiological, phenomenological, and pathophysiological evidence that suggests the specificity of depression associated with alzheimer's disease (ad). |
| PubMedID- 21845597 | depression in alzheimer's disease: specificity of depressive symptoms using three different clinical criteria. |
| PubMedID- 26401925 | A review of pharmacological treatments for depression in alzheimer's disease. |
| PubMedID- 23194378 | It is conceivable that this might be relevant in neuropsychiatric disorders as well, because tauopathy is seen when depression is co-morbid with alzheimer's disease [26]. |
| PubMedID- 26108739 | Comprehensive analysis of patient and caregiver predictors for caregiver burden, anxiety and depression in alzheimer's disease. |
| PubMedID- 25961058 | Ssris have been used to treat depression in alzheimer's disease patients. |
| PubMedID- 25649657 | Corpus callosum structure is topographically correlated with the early course of cognition and depression in alzheimer's disease. |
| PubMedID- 22568062 | The prevalence of depression in alzheimer's disease (ad) was reported 20 to 30% in population-based study. |
| PubMedID- 21949906 | Striatal hypodensities, not white matter hypodensities on ct, are associated with late-onset depression in alzheimer's disease. |
| PubMedID- 23651733 | Caregiver rating bias in mild cognitive impairment and mild alzheimer's disease: impact of caregiver burden and depression on dyadic rating discrepancy across domains. |
| PubMedID- 25654505 | The prevalence of depression in alzheimer's disease: a systematic review and meta-analysis. |
| PubMedID- 21723926 | Neuropsychiatric disorders such as depression are frequently associated with alzheimer's disease (ad) and the degeneration of cholinergic basal forebrain neurons and reductions in acetylcholine that occur in ad have been identified as potential mediators of these secondary neuropsychiatric symptomologies. |
| PubMedID- 25918972 | Effect of ninjin'yoeito, a kampo (traditional japanese) medicine, on cognitive impairment and depression in patients with alzheimer's disease: 2 years of observation. |
| PubMedID- 24314887 | depression in alzheimer's disease study 2. |
| PubMedID- 23761387 | Lc neurones degenerate early and progressively in parkinson's disease and alzheimer's disease, leading to cognitive impairment, depression and sleep disturbance. |
| PubMedID- 25208623 | Neuropathology of depression in alzheimer's disease: current knowledge and the potential for new treatments. |
| PubMedID- 22228829 | Methods: we utilized data from the depression in alzheimer's disease study 2 (diads-2), a 24-week, randomized, multicenter trial showing no significant treatment effect of sertraline on dad. |
| PubMedID- 26401763 | Phenomenology of depression in alzheimer's disease. |
| PubMedID- 23261664 | Gait and balance impairment, apathy and depression in alzheimer's disease patients suggests brainstem involvement in the initial pathogenesis. |
| PubMedID- 20087081 | The authors conducted a multicenter, randomized, placebo-controlled trial titled "depression in alzheimer's disease-2" to assess the efficacy and tolerability of sertraline for depression in ad. |
| PubMedID- 24946876 | depression in alzheimer's disease: epidemiology, mechanisms, and management. |
| PubMedID- 20672243 | Methods: diads-2 was a randomized, parallel, placebo-controlled, multicenter trial designed to evaluate the efficacy and safety of sertraline (target dose of 100 mg/day) for the treatment of depression in patients with alzheimer's disease. |
| PubMedID- 24118908 | Aim: depression in alzheimer's disease (ad) has different clinical manifestations from primary depression of non-demented patients. |
| PubMedID- 22479262 | Background: this study explores factors associated with depression in alzheimer's disease (ad) compared with mild cognitive impairment (mci) and other dementia disorders. |
| PubMedID- 22014127 | depression in alzheimer's disease: consequence or contributing factor. |
| PubMedID- 22819689 | Ethnopharmacological relevance: yokukansan, a traditional japanese medicine (kampo), has been reported in the treatment of behavioral and psychological symptoms of dementia (bpsd) such as aggression, anxiety and depression in patients with alzheimer's disease and other forms of senile dementia. |
| PubMedID- 22416213 | alzheimer's disease patients with depression have been treated with ssris in combination with cholinesterase inhibitors (donepezil, ravastigmine and galantamine) and showed better cognitive function than patients who were treated only with cholinesterase inhibitors [82]. |
| PubMedID- 20642926 | Severity and risk factors of depression in alzheimer's disease. |
| PubMedID- 20110699 | Metabolic compensation and depression in alzheimer's disease. |
| PubMedID- 21504132 | depression in alzheimer's disease. |
Page: 1